{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:27:33Z","timestamp":1793424453660,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.atherosclerosis.2022.04.005","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T20:46:13Z","timestamp":1653079573000},"page":"42-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"special_numbering":"C","title":["Lipoprotein(a) and ethnicities"],"prefix":"10.1016","volume":"349","author":[{"given":"Anurag","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vardhmaan","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anum","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Saseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S.","family":"Virani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1399-0004.1975.tb00338.x","article-title":"Lp(a) lipoprotein\/pre-beta1-lipoprotein in Swedish middle-aged males and in patients with coronary heart disease","volume":"7","author":"Dahl\u00e9n","year":"1975","journal-title":"Clin. Genet."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1399-0004.1979.tb01014.x","article-title":"Lp(a) phenotypes, other lipoprotein parameters, and a family history of coronary heart disease in middle-aged males","volume":"16","author":"Berg","year":"1979","journal-title":"Clin. Genet."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9150(81)90103-9","article-title":"Lipoprotein Lp(a) and the risk for myocardial infarction","volume":"38","author":"Kostner","year":"1981","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.ATV.5.3.265","article-title":"Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B","volume":"5","author":"Guyton","year":"1985","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0009-8981(87)90263-4","article-title":"Black-white differences in serum Lp(a) lipoprotein levels","volume":"168","author":"Parra","year":"1987","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.CIR.84.1.160","article-title":"Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children","volume":"84","author":"Srinivasan","year":"1991","journal-title":"Bogalusa Heart Study., Circulation."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-0004.1993.tb03887.x","article-title":"Serum lipoprotein(a) levels in elderly black and white men in the Charleston Heart Study","volume":"44","author":"Knapp","year":"1993","journal-title":"Clin. Genet."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/jcp.47.12.1105","article-title":"Ethnic differences in lipid and lipoprotein metabolism in pregnant women of African and Caucasian origin","volume":"47","author":"Koukkou","year":"1994","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib9","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0002-9343(92)90199-L","article-title":"Plasma lipoprotein (a) protein concentration and coronary artery disease in black patients compared with white patients","volume":"93","author":"Sorrentino","year":"1992","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ije\/23.1.20","article-title":"Comparison of serum lipoprotein(a) distribution and its correlates among black and white populations","volume":"23","author":"Bovet","year":"1994","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/BF00201550","article-title":"Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups","volume":"86","author":"Sandholzer","year":"1991","journal-title":"Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib12","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0022-2275(20)41895-4","article-title":"Contribution of the apo[a] phenotype to plasma Lp[a] concentrations shows considerable ethnic variation","volume":"32","author":"Helmhold","year":"1991","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib13","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/oxfordjournals.aje.a116571","article-title":"Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the san Antonio heart study","volume":"136","author":"Haffner","year":"1992","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/1047-2797(94)90067-1","article-title":"Concentrations of Lp(a) in black and white young adults: relations to risk factors for cardiovascular disease","volume":"4","author":"Howard","year":"1994","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1047-2797(98)00063-5","article-title":"The relationship between lipids\/lipoproteins and atherosclerosis in African Americans and whites: the Atherosclerosis Risk in Communities Study","volume":"9","author":"Sorlie","year":"1999","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCULATIONAHA.116.024611","article-title":"LPA gene, ethnicity, and cardiovascular events","volume":"135","author":"Lee","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jacl.2020.06.010","article-title":"Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort","volume":"14","author":"Brandt","year":"2020","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib18","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/ATVBAHA.114.304785","article-title":"Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis","volume":"35","author":"Guan","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.atherosclerosis.2020.09.010","article-title":"Lipoprotein (a) and aortic valve calcium in South Asians compared to other race\/ethnic groups","volume":"313","author":"Makshood","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","article-title":"Lp(a) (Lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: New insights from a large National Biobank","volume":"41","author":"Patel","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib21","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","article-title":"Interheart investigators, lipoprotein(a) levels and the risk of myocardial infarction among 7 ethnic groups","volume":"139","author":"Pare","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1172\/JCI115855","article-title":"Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations","volume":"90","author":"Boerwinkle","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF00220066","article-title":"The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration","volume":"90","author":"Kraft","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2022.04.003","article-title":"Lipoprotein(a) beyond the kringle IV repeat polymorphism: the complexity of genetic variation in the LPA gene","volume":"349","author":"Coassin","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib25","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1194\/jlr.R067314","article-title":"Structure, function, and genetics of lipoprotein (a)","volume":"57","author":"Schmidt","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib26","first-page":"1","article-title":"Apolipoproteins in vascular biology and atherosclerotic disease","author":"Mehta","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.atherosclerosis.2022.04.002","article-title":"Recent advances in demystifying the metabolism of lipoprotein(a)","volume":"349","author":"Chemello","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","article-title":"cDNA sequence of human apolipoprotein(a) is homologous to plasminogen","volume":"330","author":"McLean","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/hmg\/2.4.361","article-title":"The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms","volume":"2","author":"van der Hoek","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib30","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/hmg\/2.7.933","article-title":"Molecular definition of the extreme size polymorphism in apolipoprotein(a)","volume":"2","author":"Lackner","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib31","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1074\/jbc.272.8.5048","article-title":"Influence of allelic variation on apolipoprotein(a) folding in the endoplasmic reticulum","volume":"272","author":"White","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00041433-199504000-00003","article-title":"Biosynthesis and metabolism of lipoprotein (a)","volume":"6","author":"White","year":"1995","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib33","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.108.836940","article-title":"Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race\/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors","volume":"119","author":"Tsimikas","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000472175","article-title":"Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random","volume":"4","author":"Kraft","year":"1996","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib35","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/S0022-2275(20)37461-7","article-title":"Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans","volume":"37","author":"Marcovina","year":"1996","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/met.2011.0026","article-title":"Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk","volume":"9","author":"Enkhmaa","year":"2011","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib37","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1194\/jlr.R051904","article-title":"Lipoprotein (a): impact by ethnicity and environmental and medical conditions","volume":"57","author":"Enkhmaa","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib38","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/hmg\/8.11.2087","article-title":"Molecular basis of congenital lp(a) deficiency: a frequent apo(a) \u201cnull\u201d mutation in caucasians","volume":"8","author":"Ogorelkova","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib39","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abg8289","article-title":"Protein-coding repeat polymorphisms strongly shape diverse human phenotypes","volume":"373","author":"Mukamel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0022-2275(20)30165-6","article-title":"Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians","volume":"43","author":"Rubin","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib41","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jmg.2006.042119","article-title":"Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans","volume":"43","author":"Chretien","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1172\/JCI118015","article-title":"A pentanucleotide repeat polymorphism in the 5\u2019 control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians","volume":"96","author":"Trommsdorff","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCGENETICS.109.907642","article-title":"SHARE Investigators, Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians","volume":"3","author":"Lanktree","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014581","article-title":"Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans","volume":"6","author":"Deo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.atherosclerosis.2015.07.015","article-title":"Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians","volume":"242","author":"Khalifa","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib46","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1038\/s41467-018-04668-w","article-title":"NHLBI TOPMed Lipids Working Group, Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries","volume":"9","author":"Zekavat","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib47","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/eurheartj\/ehx174","article-title":"A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction","volume":"38","author":"Coassin","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib48","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jacc.2021.05.037","article-title":"Frequent LPA KIV-2 variants lower lipoprotein(a) concentrations and protect against coronary artery disease","volume":"78","author":"Schachtl-Riess","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13073-020-00771-0","article-title":"Investigation of a nonsense mutation located in the complex KIV-2 copy number variation region of apolipoprotein(a) in 10,910 individuals","volume":"12","author":"Di Maio","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(00)00187-X","article-title":"Distribution of serum apolipoproteins A-I and B and lipoprotein(a) in European elderly. The SENECA study","volume":"295","author":"Contois","year":"2000","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib51","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/eurheartj\/ehx166","article-title":"Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium","volume":"38","author":"Waldeyer","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib52","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/ATVBAHA.118.310865","article-title":"Genetic factors explain a major fraction of the 50% lower lipoprotein(a) concentrations in Finns","volume":"38","author":"Erhart","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib53","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1210\/jc.2007-2416","article-title":"High levels of inflammatory Biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans","volume":"93","author":"Anuurad","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2014.01.049","article-title":"Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk","volume":"234","author":"Langsted","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib55","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib56","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/01.ATV.12.10.1214","article-title":"Apo(a) isoforms predict risk for coronary heart disease. A study in six populations","volume":"12","author":"Sandholzer","year":"1992","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib57","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI115645","article-title":"Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease","volume":"89","author":"Sandholzer","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib58","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.111.045120","article-title":"Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"125","author":"Virani","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib59","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/hc3501.095214","volume":"104","author":"Sharrett","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib60","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib61","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"European Atherosclerosis Society Consensus Panel, Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib62","first-page":"e1082","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib63","first-page":"e596","article-title":"ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2022.04.005_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2022.04.015","article-title":"Lipoprotein(a) and cardiovascular and valvular diseases: a genetic epidemiological perspective","volume":"349","author":"Arsenault","year":"2022","journal-title":"Atherosclerosis"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2022.04.005_bib66","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1093\/eurjpc\/zwaa063","article-title":"Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions","volume":"28","author":"Welsh","year":"2021","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib67","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jacc.2020.06.040","article-title":"Khera Amit, lipoprotein(a) and family history predict cardiovascular disease risk","volume":"76","author":"Mehta","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib68","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jacc.2012.12.023","article-title":"Extreme lipoprotein(a) levels and improved cardiovascular risk prediction","volume":"61","author":"Kamstrup","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.04.005_bib69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2022.04.008","article-title":"Lipoprotein(a) measurement issues: are we making a mountain out of a Molehill?","volume":"349","author":"Kronenberg","year":"2022","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022001824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022001824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:52:43Z","timestamp":1758156763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915022001824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":69,"alternative-id":["S0021915022001824"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.04.005","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein(a) and ethnicities","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}